Conventional, Functional and Radiomics Assessment for Intrahepatic Cholangiocarcinoma

Overview

Journal Infect Agent Cancer

Publisher Biomed Central

Specialty Infectious Diseases

Date 2022 Mar 29

PMID 35346300

Authors

Vincenza Granata

Roberta Fusco

Andrea Belli

Valentina Borzillo

Pierpaolo Palumbo

Federico Bruno

Roberta Grassi

Alessandro Ottaiano

Guglielmo Nasti

Vincenzo Pilone

Antonella Petrillo

Francesco Izzo

Affiliations

Soon will be listed here.

Abstract

Background: This paper offers an assessment of diagnostic tools in the evaluation of Intrahepatic Cholangiocarcinoma (ICC).

Methods: Several electronic datasets were analysed to search papers on morphological and functional evaluation in ICC patients. Papers published in English language has been scheduled from January 2010 to December 2021.

Results: We found that 88 clinical studies satisfied our research criteria. Several functional parameters and morphological elements allow a truthful ICC diagnosis. The contrast medium evaluation, during the different phases of contrast studies, support the recognition of several distinctive features of ICC. The imaging tool to employed and the type of contrast medium in magnetic resonance imaging, extracellular or hepatobiliary, should change considering patient, departement, and regional features. Also, Radiomics is an emerging area in the evaluation of ICCs. Post treatment studies are required to evaluate the efficacy and the safety of therapies so as the patient surveillance.

Conclusions: Several morphological and functional data obtained during Imaging studies allow a truthful ICC diagnosis.

Citing Articles

Radiomics in Lung Metastases: A Systematic Review.

Gabelloni M, Faggioni L, Fusco R, Simonetti I, De Muzio F, Giacobbe G J Pers Med. 2023; 13(2).

PMID: 36836460 PMC: 9967749. DOI: 10.3390/jpm13020225.

Gender Medicine in Clinical Radiology Practice.

Giacobbe G, Granata V, Trovato P, Fusco R, Simonetti I, De Muzio F J Pers Med. 2023; 13(2).

PMID: 36836457 PMC: 9966684. DOI: 10.3390/jpm13020223.

Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.

Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese M Biology (Basel). 2023; 12(2).

PMID: 36829492 PMC: 9952965. DOI: 10.3390/biology12020213.

Immune checkpoint inhibition: a future guided by radiology.

Khan F, Jones K, Lyon P Br J Radiol. 2023; 96(1147):20220565.

PMID: 36752570 PMC: 10321249. DOI: 10.1259/bjr.20220565.

Multimodality Imaging Assessment of Desmoid Tumors: The Great Mime in the Era of Multidisciplinary Teams.

Simonetti I, Bruno F, Fusco R, Cutolo C, Setola S, Patrone R J Pers Med. 2022; 12(7).

PMID: 35887650 PMC: 9319486. DOI: 10.3390/jpm12071153.

References

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S . Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer. 2021; 16(1):53. PMC: 8287696. DOI: 10.1186/s13027-021-00393-0. View

Barabino M, Gurgitano M, Fochesato C, Angileri S, Franceschelli G, Santambrogio R . LI-RADS to categorize liver nodules in patients at risk of HCC: tool or a gadget in daily practice?. Radiol Med. 2020; 126(1):5-13. DOI: 10.1007/s11547-020-01225-8. View

Patrone R, Izzo F, Palaia R, Granata V, Nasti G, Ottaiano A . Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review. World J Gastrointest Oncol. 2022; 13(12):2203-2215. PMC: 8713325. DOI: 10.4251/wjgo.v13.i12.2203. View

Gabelloni M, Di Nasso M, Morganti R, Faggioni L, Masi G, Falcone A . Application of the ESR iGuide clinical decision support system to the imaging pathway of patients with hepatocellular carcinoma and cholangiocarcinoma: preliminary findings. Radiol Med. 2020; 125(6):531-537. DOI: 10.1007/s11547-020-01142-w. View

Granata V, Grassi R, Fusco R, Setola S, Belli A, Ottaiano A . Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features. Radiol Med. 2021; 126(12):1584-1600. DOI: 10.1007/s11547-021-01428-7. View

Granata V, Bicchierai G, Fusco R, Cozzi D, Grazzini G, Danti G . Diagnostic protocols in oncology: workup and treatment planning. Part 2: Abbreviated MR protocol. Eur Rev Med Pharmacol Sci. 2021; 25(21):6499-6528. DOI: 10.26355/eurrev_202111_27094. View

Granata V, Fusco R, Amato D, Albino V, Patrone R, Izzo F . Beyond the vascular profile: conventional DWI, IVIM and kurtosis in the assessment of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2020; 24(13):7284-7293. DOI: 10.26355/eurrev_202007_21883. View

Granata V, Fusco R, Maio F, Avallone A, Nasti G, Palaia R . Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases. Infect Agent Cancer. 2019; 14:40. PMC: 6882051. DOI: 10.1186/s13027-019-0264-3. View

10.

Gatti M, Calandri M, Bergamasco L, Darvizeh F, Grazioli L, Inchingolo R . Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Radiol Med. 2020; 125(4):348-355. DOI: 10.1007/s11547-019-01127-4. View

11.

Orlacchio A, Chegai F, Roma S, Merolla S, Bosa A, Francioso S . Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study. Radiol Med. 2019; 125(1):98-106. DOI: 10.1007/s11547-019-01093-x. View

12.

Granata V, Fusco R, Avallone A, Catalano O, Filice F, Leongito M . Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infect Agent Cancer. 2017; 12:23. PMC: 5410075. DOI: 10.1186/s13027-017-0132-y. View

13.

Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M . Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows. Oncotarget. 2017; 8(31):51224-51237. PMC: 5584244. DOI: 10.18632/oncotarget.17227. View

14.

Granata V, Fusco R, Filice S, Incollingo P, Belli A, Izzo F . Comment on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI. Radiol Oncol. 2019; 53(3):369-370. PMC: 6765167. DOI: 10.2478/raon-2019-0031. View

15.

Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R . The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer. 2018; 13:23. PMC: 6029348. DOI: 10.1186/s13027-018-0194-5. View

16.

Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P . Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019; 24(10):e990-e1005. PMC: 6795153. DOI: 10.1634/theoncologist.2018-0337. View

17.

Granata V, Palaia R, Albino V, Piccirillo M, Venanzio Setola S, Petrillo A . Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report. Eur Rev Med Pharmacol Sci. 2020; 24(12):7051-7057. DOI: 10.26355/eurrev_202006_21698. View

18.

De Filippo M, Ziglioli F, Russo U, Pagano P, Brunese L, Bertelli E . Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes. Radiol Med. 2020; 125(8):790-797. DOI: 10.1007/s11547-020-01175-1. View

19.

Arrigoni F, Bruno F, Gianneramo C, Palumbo P, Zugaro L, Zoccali C . Evolution of the imaging features of osteoid osteoma treated with RFA or MRgFUS during a long-term follow-up: a pictorial review with clinical correlations. Radiol Med. 2020; 125(6):578-584. DOI: 10.1007/s11547-020-01134-w. View

20.

Granata V, Grassi R, Fusco R, Setola S, Palaia R, Belli A . Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge. Front Oncol. 2020; 10:560952. PMC: 7731725. DOI: 10.3389/fonc.2020.560952. View